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Neuropeptide signalling systems in flatworms
Abstract
Two distinct families of neuropeptides are known to endow platyhelminth nervous systems – the
FMRFamide-like peptides (FLPs) and the neuropeptide Fs (NPFs). Flatworm FLPs are structurally simple,
each 4–6 amino acids in length with a carboxy terminal aromatic-hydrophobic-Arg-Phe-amide motif. Thus far,
four distinct flatworm FLPs have been characterized, with only one of these from a parasite. They have a
widespread distribution within the central and peripheral nervous system of every flatworm examined,
including neurones serving the attachment organs, the somatic musculature and the reproductive system. The
only physiological role that has been identified for flatworm FLPs is myoexcitation. Flatworm NPFs are
believed to be invertebrate homologues of the vertebrate neuropeptide Y (NPY) family of peptides. Flatworm
NPFs are 36–39 amino acids in length and are characterized by a caboxy terminal GRPRFamide signature and
conserved tyrosine residues at positions 10 and 17 from the carboxy terminal. Like FLPs, NPF occurs
throughout flatworm nervous systems, although less is known about its biological role. While there is some
evidence for a myoexcitatory action in cestodes and flukes, more compelling physiological data indicate that
flatworm NPF inhibits cAMP levels in a manner that is characteristic of NPY action in vertebrates. The
widespread expression of these neuropeptides in flatworm parasites highlights the potential of these signalling
systems to yield new targets for novel anthelmintics. Although platyhelminth FLP and NPF receptors await
identification, other molecules that play pivotal roles in neuropeptide signalling have been uncovered. These
enzymes, involved in the biosynthesis and processing of flatworm neuropeptides, have recently been
described and offer other distinct and attractive targets for therapeutic interference.
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SUMMARY
Two distinct families of neuropeptides are known to endow platyhelminth nervous systems – the FMRFamide-like
peptides (FLPs) and the neuropeptide Fs (NPFs). Flatworm FLPs are structurally simple, each 4–6 amino acids in length
with a carboxy terminal aromatic-hydrophobic-Arg-Phe-amide motif. Thus far, four distinct ﬂatworm FLPs have been
characterized, with only one of these from a parasite. They have a widespread distribution within the central and peripheral
nervous system of every ﬂatworm examined, including neurones serving the attachment organs, the somatic musculature
and the reproductive system. The only physiological role that has been identiﬁed for ﬂatworm FLPs is myoexcitation.
Flatworm NPFs are believed to be invertebrate homologues of the vertebrate neuropeptide Y (NPY) family of peptides.
Flatworm NPFs are 36–39 amino acids in length and are characterized by a caboxy terminal GRPRFamide signature and
conserved tyrosine residues at positions 10 and 17 from the carboxy terminal. Like FLPs,NPF occurs throughout ﬂatworm
nervous systems, although less is known about its biological role.While there is some evidence for amyoexcitatory action in
cestodes and ﬂukes, more compelling physiological data indicate that ﬂatwormNPF inhibits cAMP levels in a manner that
is characteristic of NPY action in vertebrates. The widespread expression of these neuropeptides in ﬂatworm parasites
highlights the potential of these signalling systems to yield new targets for novel anthelmintics. Although platyhelminth
FLP and NPF receptors await identiﬁcation, other molecules that play pivotal roles in neuropeptide signalling have been
uncovered. These enzymes, involved in the biosynthesis and processing of ﬂatworm neuropeptides, have recently been
described and oﬀer other distinct and attractive targets for therapeutic interference.
Key words: Platyhelminthes, trematode, cestode, turbellarian, planarian, FMRFamide, neuropeptide F, prohormone
convertase, amidation.
INTRODUCTION
Investigations of the functional neuromuscular bi-
ology of parasitic platyhelminths historically focused
on small molecule, classical neurotransmitters such
as acetylcholine, serotonin and catecholamines. The
excitatory action of serotonin and the inhibitory
action of acetylcholine (ACh) on ﬂuke muscle prep-
arations was described over 50 years ago (Chance &
Mansour, 1953). These systems have provided tar-
gets for anthelmintic drugs; for example, cholinergic
agonists have been used to treat tapeworm infections.
In comparison, it was only recently that the
importance of neuropeptides in platyhelminths has
been recognised by parasitologists. The previous
chapter of this supplement (Ribiero, El-Shehabi &
Patocka, in this supplement) exposes some of the
impediments to the study of ﬂatworm neuro-
muscular biology. Add to these the relatively recent
awareness of the biological importance of neuro-
peptides in the phylum, and the understanding of the
neuromuscular role of ﬂatworm neuropeptides is
truly in its nascency. However, even at this early
stage, there are reasons to believe that neuropep-
tidergic systems could yield novel drug targets for a
whole new generation of anthelmintic drugs.
There is clear evidence that neuropeptides are
central to the biology of ﬂatworms and, as illus-
tration, neuropeptide immunostaining outstrips that
reported for classical transmitter molecules in ﬂat-
worms (Halton &Maule, 2004). Two distinct classes
of neuropeptides have been identiﬁed within the
phylum. Firstly, there are FMRFamide-like pep-
tides (FLPs), which are relatively short peptides
(typically <20 amino acids) ending in a carboxy-
terminal RFamide motif. Secondly, there are neuro-
peptide Fs (NPFs), which are larger peptides (36–40
amino acids) that are related to the vertebrate
neuropeptide Y (NPY) family of peptides.
In addition to playing a central role in ﬂatworms,
the importance of neuropeptides in nematodes has
also become apparent. One inaccurate concept is that
the two phyla of worms are very similar, such that
things learned from the nematodes can be easily ex-
trapolated to the platyhleminths. The other extreme
would also be inaccurate – that is, to think that the
worms are completely dissimilar such that there will
be no commonalities between the two phyla. This
principle can be illustrated in the context of a
quick overview of platyhemlinth neuropeptides in
comparison to nematode neuropeptides.
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The most easily noted disparity between the two
phyla is the dramatic disproportion in the breadth of
neuropeptides expressed by worms from the two
groups. Each nematode species has a staggering
complement of apparent neuropeptides, with at least
236 distinct peptides encoded in the genome of
C. elegans and 67 of these being FLPs (Li, Kim &
Nelson, 1999; Pierce et al. 2001; Kim & Li, 2004;
McVeigh et al. 2005). This wide neuropeptide
complement is apparent in parasitic nematodes as
well, where biochemical and genetic information has
conﬁrmed at least 27 distinct FLPs in Ascaris suum
(Davis & Stretton, 1996; Yew et al. 2005). Compared
to this staggering complement of FLPs present in
typical free-living and parasitic species of nematodes,
only one or two distinct FLPs have been found in
each platyhelminth species thus far examined. While
it is possible that some of these speciesmay contain as
yet undetected FLPs, it does not seem possible that
there is anywhere close to the complement of FLPs in
ﬂatworms that are found in nematodes. Another
diﬀerence between the phyla relates to the neuro-
peptide F (NPF) family of peptides. The NPFs are
abundant in every platyhelminth thus far examined.
However, the presence of the NPF family of peptides
has not yet been established in the nematodes, and
it seems likely that they may be absent from the
phylum altogether.
Pointing out these diﬀerences might lead to the
impression that there is little commonality in the
neuropeptidergic components of the two phyla of
worms, but that is not the case. Although the
breadth of FLPs is diﬀerent in the two phyla, some
of the FLPs share a great deal of similarity. As a
testimony, FLPs from each phylum have activity
in the other; for example, a number of nematode
FLPs are myoexcitatory in ﬂatworm preparations
(Mousley et al. 2004). Also, there are compo-
nents of the neuropeptidergic systems that appear
to be common to both phyla, such as the neuro-
peptide receptors, the proteins involved in signal
transduction, the processing enzymes involved in
the generation of active neuropeptides and, possibly,
the proteases involved in terminating neuropeptide
signalling.
There is reason to believe that these neuro-
peptidergic systems could yield novel drug targets.
Firstly, the neuropeptide signalling systems are
widespread and important in parasitic ﬂatworms
(Halton & Gustafsson, 1996). Although we have
much to learn, there is little doubt of the central role
of neuropeptides in ﬂatworm biology; one clear role
for neuropeptides is in the control of motor function
(Day&Maule, 1999). In contrast, at least some of the
neuropeptides present in parasitic ﬂatworms have
restricted roles in their mammalian hosts. Also, the
endogenous neuropeptides are remarkably potent in
parasitic worms; in schistosomes, some peptides
have threshold activities in the low nanomolar or
high picomolar range (Day et al. 1997; Humphries
et al. 2004).
This paper will provide an overview of what is
known about the role of neuropeptides in platy-
helminths, keeping an eye on the consideration that
molecules involved in the neuropeptidergic signal-
ling could be attractive targets for novel drugs to treat
infections with platyhelminths. Elsewhere in this
supplement, the possibility of these targets crossing
phyla lines is considered in great detail (Mousley,
Maule & Marks, in this supplement).
FMRFAMIDE-LIKE PEPTIDES (FLPS)
Structure of ﬂatworm FLPs
FLPs (also referred to as FMRFamide-related
peptides, or FaRPs) are, as their name suggests,
somewhat like the seminal neuropeptide sequence
of FMRFamide, isolated from the Venus clam
Macrocallista nimbosa by virtue of its cardioexcita-
tory activity (Price & Greenberg, 1977). This group
now represents the largest family of neuropeptides
known in the invertebrates. FLPs are abundant and
widespread within ﬂatworms, but the structural
diversity characteristic of FLPs in other invertebrate
phyla is lacking. All currently identiﬁed ﬂatworm
FLPs conform to the formal FLP carboxy terminal
motif of (F/Y)XRFamide, where X denotes a vari-
able hydrophobic residue (Greenberg et al. 1988;
Shaw, Maule & Halton, 1996; Espinoza et al. 2000).
In contrast to the structural complexity of the
platyhelminth nervous system, with its characteristic
orthogonal arrangement (Halton & Gustafsson,
1996), ﬂatworms appear to be rather straightforward
in terms of neuropeptide diversity. There was a
ﬂurry of reports identifying four ﬂatworm FLPs
around a decade ago (Maule et al. 1993b, 1994;
Johnston et al. 1995b, 1996) (see Table 1), but no
novel structural or molecular characterizations have
since been reported, and no FLPs have yet been
isolated from the trematodes.
The current lack of structural peptide data from
these important parasites can be attributed to their
generally small size and scarcity, which practically
preclude peptide discovery through the tissue-
hungry techniques of acid-ethanol extraction, HPLC
Table 1. FMRFamide-like (FLPs) biochemically
identiﬁed from platyhelminths
Species Sequence Reference
Moniezia expansa GNFFRF
amide
Maule et al. 1993b
Arthurdendyus
triangulatus
RYIRF amide Maule et al. 1994
Girardia tigrina GYIRF amide Johnston et al. 1995b
Bdelloura candida GYIRF amide Johnston et al. 1996
Bdelloura candida YIRF amide Johnston et al. 1996
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and peptide sequencing. As an example, isolation
and structural analysis of the cestode FLP,
GNFFRFamide, required an initial amount of 1 kg
Moniezia expansa tissue (Maule et al. 1993b ; Shaw
et al. 1996). Such relativelymassive amounts of tissue
are viable when dealing with large, easily obtained
species such as tapeworms, but are problematic when
dealing with the small and relatively rare trematodes.
Greater success has been achieved with isolations
from turbellarian tissue. These free-living platy-
helminths express higher levels of neuropeptides in
their nervous systems, a feature which could be at
least partly attributable to the greater mobility
demanded by free-living worms as compared to some
of their parasitic cousins who have a lower overall
requirement for neuromuscular dexterity when
residing within the host environment (Johnston et al.
1995a). This results in a higher ratio of peptide to
wet weight of tissue in turbellarians and, in addition
to the readily available supply of many of these
species, accounts for the greater success of neuro-
peptide extractions from these worms.
The ﬁrst identiﬁed ﬂatworm FLP, GNFFRF-
amide from the sheep tapewormM. expansa (Maule
et al. 1993b), has since been resolved as an atypical
member of the small family of platyhelminth FLPs.
The FLPs characterized from turbellarians are tetra/
pentameric and share a characteristic YIRFamide
carboxy terminus. Despite its double aromatic
motif, GNFFRFamide is still consistent with the
generalised FLP structure, since phenylalanine
possesses both aromatic and hydrophobic charac-
teristics. The distinct structure of this cestode FLP
may reﬂect the relative evolutionary relationships
between the platyhelminth classes; cestodes are
considered the most derived class of ﬂatworms. With
further regard to evolutionary lineages, it has been
postulated that the turbellarian FLPs – not
FMRFamide – represent the ancestral FLPstructure
in invertebrates, since bilaterian ﬂatworms could
represent the evolutionary progenitors of all invert-
ebrate phyla (Shaw, Maule & Halton, 1996).
No molecular data have yet been published
regarding FLP gene structure in platyhelminths.
Although molecular techniques eliminate many of
the inherent diﬃculties associated with lack of source
tissue, eﬀectively allowing ampliﬁcation of cDNA
from milligram amounts of tissue (Matz, 2002,
2003), neuropeptide genes are nevertheless expressed
at low levels, compounding the diﬃculties associated
with the oft-attempted but rarely successful approach
of PCR ampliﬁcation using degenerate oligonucleo-
tides. Further, ﬂatworm biology has not, until very
recently, beneﬁted from the establishment of genome
sequencing programmes and associated expressed
sequence tag (EST) generation. In contrast, parasitic
nematodes have enjoyed such attention, resulting in
the successful identiﬁcation of numerous ﬂp gene
candidates from a range of species (McVeigh et al.
2005). The ongoing surge of interest in bio-
informatics has now led to the initiation of genome
projects for Schistosoma (El-Sayed et al. 2004;
LoVerde et al. 2004) and the turbellarian Schmidtea
mediterranea (Sanchez Alvarado et al. 2002; Reddien
et al. 2005), in addition to the EST programmes in
S. mansoni and S. japonicum and other parasitic
species including Echinococcus granulosus, E. multi-
locularis, Mesocestoides corti, Echinostoma paraensi,
Fasciola hepatica andClonorchis sinensis as well as the
important free-living models Dugesia ryukyuensis
and D. japonicum (http://www.ncbi.nlm.nih.gov/
dbEST dbEST release 051305). Even cursory
searches of these databases reveal many sequences
encoding putative FLPs, but as yet no ﬂp genes have
been characterized. The impending completion of
the S. mansoni genome project (LoVerde et al. 2004)
should provide resources for the molecular char-
acterization of transcripts encoding neuropeptides
and their receptors in a manner similar to those of the
Caenorhabditis elegans and Drosophila melanogaster
projects. S. mansoni genome data should also provide
a springboard for the similarity-based identiﬁcation
of homologous genes in other ﬂatworms.
Localisation of ﬂatworm FLPs
FLP localisation studies have traditionally employed
immunocytochemical (ICC) techniques coupled to
confocal scanning laser microscopy (CSLM) (Halton
& Maule, 2004). Such methods have been useful
because they typically require only a short peptide
sequence to enable antigen preparation and sub-
sequent generation of speciﬁc antisera. Consequently
ICC has been applied to the localisation of en-
dogenous FLPs isolated from ﬂatworms in the
absence of the molecular sequence information
which would allow employment of the much more
speciﬁc technique of in situ hybridisation (ISH).
However, the current and continuing increase in
genetic sequence data from platyhelminths will
allow design of DNA/RNA probes for use in ISH
techniques in the near future, enabling useful and
interesting comparisons to be made regarding the
speciﬁcity of existing FLP immunolocalisation.
FLP distribution has been extensively reviewed
over the years (Shaw et al. 1996; Day &Maule, 1999;
Maule et al. 2002; Halton & Maule, 2004) and will
not be repeated in detail here. In short, FLP
immunoreactivity (FLP-IR) has been reported in a
wide variety of species, including representatives of
all major platyhelminth groups. The typical ﬂat-
worm nervous system consists of a central nervous
system (CNS), comprised of a bi-lobed brain and
paired longitudinal nerve cords, and a peripheral
nervous system, comprised of a number of nerve
nets somewhat reminiscent of the plexuses seen in
cnidaria. Generally FLP-IR is widespread within
ﬂatworms and has been described in the innervation
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of locomotory muscle, attachment structures, the
alimentary system and reproductive organs.
Distribution includes both these peripheral neuronal
elements and neurones of the central nervous system.
FLP distribution patterns mirror those of the
classical transmitter ACh in monogeneans (Maule
et al. 1990b ; Cable et al. 1996; Zurawski et al. 2001)
and trematodes (Stewart, Marks & Halton, 2003). In
neuromuscular innervation at least, the apparently
complementary distribution of an inhibitory trans-
mitter (ACh) with the wholly excitatory FLPs seems
rational in terms of these two neurotransmitters
performing a co-modulatory role in neuromuscular
co-ordination. The existence of separate neuronal
pathways for FLPs and serotonin have been dem-
onstrated in the majority of species examined (Maule
et al. 1990a ; Biserova et al. 2000; Zurawski et al.
2001; Kotikova et al. 2002; Stewart, Marks &
Halton, 2003; Stewart et al. 2003a, b) with the
exception of ootype innervation in the trematode
Echinostoma caproni, which includes cells displaying
the apparent co-localisation of serotonin and FLP
immunoreactivities (Sˇebelova´ et al. 2004). Since
there is evidence that serotonin acts to maintain the
contractile activity of ﬂatworm muscle through
stimulation of cAMP levels (Day, Bennett & Pax,
1994), it has been suggested that serotonin might
maintain muscular energy levels through elevation of
cAMP in ootype cells, and that the FLP(s) trigger the
onset of egg production (Sˇebelova´ et al. 2004).
However, no data are available from ﬂatworms
regarding interactions between FLP signalling and
cAMP levels.
Such observations as those of Sˇebelova´ et al. (2004)
regarding FLP involvement in ﬂatworm repro-
ductive function have long been a focus for parasite
neurobiologists, because pharmacological inter-
ference with reproductive function could have
signiﬁcant therapeutic value. Perhaps the strongest
evidence implicating FLPs in reproductive function
of ﬂatworms is that regarding the FLPergic system of
Polystoma nearcticum, a monogenean parasite of the
grey treefrog, Hyla versicolor. This parasite lives
within the host urinary bladder, in reproductive
synchrony with its anuran host. An ICC study has
shown that while serotonin-IR of the parasite’s
reproductive apparatus remains constant, FLP-IR
can only be demonstrated during host spawning
(Armstrong et al. 1997), suggesting an intrinsic and
regulated role for FLPs in the modulation of ﬂat-
worm reproduction. The involvement of FLPs
in reproductive function is further supported by
a recent developmental study showing that FLP
innervation of the reproductive system of two
strigeid trematodes could only be demonstrated fol-
lowing the onset of egg production (Stewart, Marks
& Halton, 2003). The collective evidence strongly
supports a role for FLPs in ﬂatworm reproductive
function.
Physiology of ﬂatworm FLP signalling
The earliest studies aiming to characterize the eﬀects
of putative transmitters on ﬂatworm muscle utilised
muscle strip or whole worm assays (Chance &
Mansour, 1949, 1953; Paasonen & Vartiainen, 1958;
Terada et al. 1982). These approaches have been
successful in characterizing the excitatory action
of FLPs on ﬂatworm somatic muscle, including
Diclidophora merlangi (Maule et al. 1989b ; Money-
penny et al. 1997),E. caproni (Humphries et al. 2000)
and F. hepatica (Marks et al. 1996; Graham, Fair-
weather & McGeown, 1997). These investigations
provide evidence of the myoexcitatory actions of
platyhelminth FLPs, but the inherent drawback of
such studies is that they cannot discriminate between
neuropeptide eﬀects on muscle and those on nerve or
other tissues. For example, it is diﬃcult to determine
if the excitatory eﬀects on a whole worm are due to
direct excitation of the muscle, an eﬀect on motor
neurones or a combination of both. The acoelomate
anatomy of ﬂatworms renders the denervation of
muscle tissue by dissection practically impossible.
An alternative method of separating muscle from
nerve tissue was developed using schistosomes (Blair
et al. 1991) in which enzymatic digestion produced
dispersed, individual muscle ﬁbres which retained
their contractile qualities. This preparation not only
allows direct study of neurotransmitter eﬀects on
muscle ﬁbres free from interference caused by
extraneous tissues (which in standard tissue prep-
arations can hinder access of polar compounds to
muscle-based receptors), but with the removal of
these extraneous tissues the site of excitation can be
more deﬁnitively localised to the muscle. The excit-
atory eﬀects of ﬂatworm FLPs on isolated muscle
ﬁbres have been reported in S. mansoni (Day et al.
1994), Bdelloura candida (Johnston et al. 1996) and
Procerodes littoralis (Moneypenny et al. 2001), sug-
gesting that an FLP receptor resides on ﬂatworm
muscle ﬁbres. The presence of an FLP-speciﬁc
receptor on the somatic musculature is further sub-
stantiated by the speciﬁcity of FLP myoexcitation.
For example, single amino acid substitutions were
suﬃcient to cause ﬂatworm FLPs to lose their
activity on schistosome muscle preparations (Day
et al. 1997).
Further conﬁrmation of the existence of a single
muscle-based FLP receptor is provided by studies
utilisingpeptide analogues incorporating thed isomer
of phenylalanine (dF). These inactive forms com-
petitively inhibit the excitatory eﬀects of ﬂatworm
FLPs. A GYIRFamide analogue (GYIRdFamide)
blocks the contractile eﬀects of GYIRFamide,
YIRFamide and GNFFRFamide on isolated
turbellarian muscle cells (Moneypenny et al. 2001).
Similarly, FMRdFamide blocked the contractile
eﬀects of both FMRFamide and GNFFRFamide on
S. mansoni muscle ﬁbres (Day et al. 1994) (Table 2).
P. McVeigh and others S44
Table 2. The potency of FMRFamide-like peptides (FLPs) excitation of platyhelminth muscle preparations
Source phylum FLP sequence Flatworm tissue type Potency Reference
Mollusca FMRF.NH2 Schistosoma mansoni isolated ﬁbres 0.01 T Day et al. 1994
Fasciola hepatica muscle strips 0.5 T Graham et al. 1997
FLRF.NH2 Fasciola hepatica muscle strips 0
.5 T Graham et al. 1997
Procerodes littoralis isolated ﬁbres 1 T Moneypenny et al. 2001
YIRF.NH2 Diclidophora merlangi trimmed 0
.01 T Moneypenny et al. 1997
Fasciola hepatica trimmed (j) 0.3 T Marks et al. 1996
Schistosoma mansoni isolated ﬁbres 0.004 E Day et al. 1997
Procerodes littoralis isolated ﬁbres 0.001 T Moneypenny et al. 2001
Fasciola hepatica muscle strips 0.05 T Graham et al. 1997, 2000
GYIRF.NH2 Fasciola hepatica trimmed (j) 0
.3 T Marks et al. 1996
Diclidophora merlangi trimmed 0.1 T Moneypenny et al. 1997
Schistosoma mansoni isolated ﬁbres 0.001 E Day et al. 1997
Platyhelminthes Schistosoma mansoni isolated ﬁbres 0.001 T Day et al. 1994
Fasciola hepatica trimmed (j) 0.001 T Marks et al. 1996
RYIRF.NH2 Fasciola hepatica muscle strips 0.5 T Graham et al. 1997
Diclidophora merlangi trimmed 0.1 T Moneypenny et al. 1997
Schistosoma mansoni isolated ﬁbres 0.007 E Graham et al. 1997
Procerodes littoralis isolated ﬁbres 0.01 T Moneypenny et al. 2001
Schistosoma mansoni isolated ﬁbres 0.1 T Day et al. 1994
GNFFRF.NH2 Fasciola hepatica trimmed (j) 10 T Marks et al. 1996
Fasciola hepatica muscle strips NE Graham et al. 1997
Diclidophora merlangi trimmed NE Moneypenny et al. 1997
Schistosoma mansoni isolated ﬁbres 0.5 E Day et al. 1997
KPNFIRF.NH2 Fasciola hepatica trimmed (j) 0.03 T Marks et al. 1996
Fasciola hepatica muscle strips 5 T Graham et al. 1997
KHEYLRF.NH2 Fasciola hepatica muscle strips 0
.5 T Graham et al. 1997
Fasciola hepatica trimmed (j) 1 T Marks et al. 1997
Nematoda KSAYMRF.NH2 Fasciola hepatica muscle strips 0.5 T Graham et al. 1997
Fasciola hepatica trimmed (j) 3 T Marks et al. 1996
KNEFIRF.NH2 Fasciola hepatica trimmed (j) 3 T Marks et al. 1997
Fasciola hepatica muscle strips 5 T Graham et al. 1997
SDPNFLRF.NH2 Fasciola hepatica trimmed (j) 10 T Marks et al. 1997
SADPNFLRF.NH2 Fasciola hepatica trimmed (j) 10 T Marks et al. 1997
DPSFLRF.NH2 0
.029 E
pQDVDHVFLRF.NH2 0
.033 E
KPNQDFMRF.NH2 0
.059 E
HVFLRF.NH2 0
.128 E
Arthropoda VFLRF.NH2 Procerodes littoralis isolated ﬁbres 0.286 E Mousley et al. 2004
TNRNFLRF.NH2 0
.384 E
PDVDHVFLRF.NH2 0
.502 E
EQFDDY (SO3H)GHMRF 0
.594 E
GNSFLRF.NH2 1
.257 E
SDRNFLRF.NH2 1
.69 E
NE=no measurable eﬀect; T=potency reported as threshold concentration; E=potency reported as EC50, the concentration producing half of the maximal eﬀect; (j)=juvenile worms; eﬀects are on adult
worms unless denoted as juvenile.
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FLP signalling
Graham, Fairweather &McGeown (2000) published
the only report on FLP signalling, investigating
GYIRFamide-induced excitation in muscle strips
of the trematode F. hepatica. This study used a
physiological approach to monitor the activity of
GYIRFamide in the presence of pharmacological
modulators of intracellular signalling pathways.
Results suggest that GYIRFamide signals through
a G protein-coupled receptor (GPCR) pathway
involving activation of phospholipase C (PLC) and
protein kinase C (PKC). These are both constituents
of the phosphatidylinositol pathway, which involves
G-protein activation of PLC, an enzyme which pro-
cesses phosphatidylinositol (4,5) bisphosphate (PIP2)
into inositol (1,4,5) triphosphate (IP3) and diacyl-
glycerol (DAG). DAG stimulates PKC to activate
eﬀector proteins such as enzymes, contractile pro-
teins and ion channels. The myomodulatory activity
of PKC has also been demonstrated in S. mansoni,
where phorbol esters, well known activators of PKC,
produced spastic paralysis of schistosome muscu-
lature (Blair, Bennett & Pax, 1988), and in Bdelloura
candida where these compounds caused partial tonic
paralysis of whole worms (Blair & Anderson, 1994).
IP3 acts to release sequestered Ca
2+ from the sarco-
plasmic reticulum (SR) through IP3 receptor
channels. Although other studies have shown that
PLC stimulation leads to IP3 production in the
cestodeHymenolepis diminuta (Samii & Webb, 1996)
and S. mansoni (Wiest et al. 1992), these have not yet
been directly linked to the FLP signalling system.
These pathways indirectly implicate the presence of
a functional SRwithin ﬂatwormmuscle cells. In fact,
SR components have been demonstrated in ﬂatworm
tissue, including the presence of ryanodine receptor
(RyR) channels capable of supporting contraction of
schistosomemuscle (Day et al. 2000). TheS. mansoni
SR is also imbued with thapsigargin-sensitive Ca2+
pumps, which allow sequestration of cytosolic Ca2+
(Noel et al. 2001).
The involvement of extracellular Ca2+ inﬂux
through voltage-gated channels in contractile activity
has been demonstrated in the turbellarian Dugesia
tigrina (Cobbett & Day, 2003), and the trematodes
F. hepatica (Graham, McGeown & Fairweather,
1999) and S. mansoni (Day et al. 1994). Although
there are some data implicating extracellular Ca2+ in
the FLP-induced contractions (Day et al. 1994), the
conduit for that inﬂux and how it is coupled to PKC
is unclear.
In summary, although FLPs are abundant and
important in ﬂatworms their biological functions and
the associated signalling pathways remain unclear.
There are reasons to believe that some of these issues
can be illuminated in the next few years. Firstly, the
study of dispersed muscle ﬁbres is expanding and
more data should accumulate regarding the events
associated with FLP-induced myoexcitation. For
example, the protocol has been successfully applied
to F. hepatica (Kumar et al. 2003, 2004). Secondly,
more techniques are now becoming available to
investigate the functional biology of ﬂatworms, such
as RNA interference (Boyle et al. 2003; Skelly,
Da’dara & Harn, 2003) and genetic transformation
(Wippersteg et al. 2002, 2003, 2005; Gonzalez-
Estevez et al. 2003; Heyers et al. 2003). These should
lead to the application of a range of molecular
manipulations such as gene silencing or over-
expression, as well as ﬂuorescent protein-based
expression analyses.
NEUROPEPTIDE FS (NPFS)
Structure of ﬂatworm NPFs
The earliest suggestions that platyhelminths pos-
sessed neuropeptides similar to the vertebrate
neuropeptide Y (NPY) family came from immuno-
cytochemistry. In the 1980s and into the early 1990s,
there were many reports of NPY family-IR in ﬂat-
worms, and the most intense staining was usually
noted with antisera targeting the carboxy terminus of
pancreatic polypeptide (PP), a member of the NPY
family (Larhammar, 1996; Balasubramaniam, 1997,
2003). PP-IR has been recorded throughout the
nervous systems of every species examined; as well
as the extensive staining throughout the CNS
PP-immunopositive nerve plexuses serve the repro-
ductive structures, the sub-tegumental muscle
layers, the holdfast organs and the alimentary sys-
tems of ﬂatworms. For example, in S. mansoni, there
is extensive PP-IR in the nerve ﬁbres surrounding
the muscular egg chamber and at the entrances of the
oviducts (Skuce et al. 1990;Marks et al. 1995). There
is also extensive staining in the nerve plexuses serv-
ing the subtegumental, somatic muscle layers (Skuce
et al. 1990), and the suckers that the male worms use
for attachment within the vasculature (Marks et al.
1995). PP-IR is also abundant in nerves approaching
the oesophagus of schistosomes that leads from the
mouth to the blind-ending gut.
The neuronal location of PP-IR in ﬂatworms
suggested that the parasite antigens responsible were
akin to vertebrate NPY. Furthermore, there was
chromatographic evidence that the parasite antigens
were structurally similar to the 36 amino acid peptide
common to NPY family members. Chromatographic
analysis of peptide extracts from D. merlangi (Maule
et al. 1989a), M. expansa (Maule et al. 1991) and
S. mansoni (Humphries et al. 2004) found a single
peak of PP immunoreactivity which co-eluted with
other NPY family members from columns which
separate on the basis of size and hydrophobicity.
This type of evidence led to the hypothesis that there
was an NPY-like neuropeptide present in ﬂatworms
even before the identiﬁcation of a speciﬁc peptide
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from the phylum.There was also evidence for similar
peptides in other closely-related invertebrates
(Maule, Halton & Shaw, 1995), and they also ap-
peared to be abundant and widespread in the nervous
system.
The ﬁrst identiﬁcation of an NPY-like neuro-
peptide in a ﬂatworm was via biochemical puriﬁ-
cation of the PP immunoreactive peak from the
tapeworm M. expansa (Maule et al. 1991, 1992a).
The tapeworm neuropeptide is 39 amino acids in
length and has striking similarity to peptides of the
NPY family, which are typically 36 amino acids in
length. The peptide was named neuropeptide F
(NPF) because it features a carboxy terminal Phe (F)
residue, in contrast to NPY’s carboxy terminal Tyr
(Y). The discovery of M. expansa NPF (mxNPF)
was the ﬁrst NPF identiﬁed in any animal, and it was
also the ﬁrst neuropeptide identiﬁed in a platyhel-
minth. Subsequent to the identiﬁcation of mxNPF,
similar peptides have been identiﬁed in other
animals, including other platyhelminths (Table 3).
In addition to the cestode Moniezia, NPFs have
been identiﬁed in the turbellarian Arthurdendyus
triangulatus (Curry et al. 1992; Dougan et al. 2002)
and the trematodes S. mansoni and S. japonicum
(Humphries et al. 2004). All of these NPFs feature a
carboxy terminal GRPRFamide motif, are 36 amino
acids in length (except mxNPF which is 39 amino
acids long), and have conserved Y residues at
positions 10 and 17 relative to the carboxy terminus,
the hallmark feature of NPY family peptides.
Immunolocalisation of ﬂatworm NPFs
NPF-immunoreactivity (NPF-IR) is abundant and
widespread throughout the nervous system of every
ﬂatworm species examined, which includes over 30
species. Previous reviews have provided extensive
reports of these staining patterns (Day & Maule,
1999; Maule et al. 2002; Halton &Maule, 2004), and
only a summary will be provided here.
Firstly, NPF-IR occurs exclusively in neural
elements in ﬂatworms. NPF is abundantly expressed
in the CNS of ﬂatworms, including in the bi-lobed
brain, themain nerve cords and the commissures that
connect the two main nerve cords as they progress
away from the brain. NPF-IR is also present inmuch
of the peripheral nervous system. The nerve ﬁbres
serving most of the distinct muscle systems of ﬂat-
worms are replete with NPF-IR, including the
somatic muscle layers, the holdfast organs, the
reproductive structures and the alimentary system.
Though the speciﬁc orientation and grouping of
somatic musculature in the diﬀerent classes within
the platyhelminths is variable, there is consistently
NPF-IR throughout the nerves associated with these
muscle layers. Schistosomes are an apt example.
Schistsomes have a rather complex organization of
body muscle which lies in three distinct layers –
circular, longitudinal and diagonal – directly under-
neath the worm’s outer tegument (Mair et al. 2000b).
These muscle layers are invested with NPF-
immunoreactive neural elements (Skuce et al.
1990), and this appears typical as it is repeated in
all other ﬂatworms examined, which includes
examples from each class (Maule et al. 1993a ; Reuter
et al. 1995a, b). The parasitic platyhelminths also
feature distinct muscle groupings in their holdfast
organs, which are critical for the maintenance of
proper position within or on the host and which are
also suppliedwithNPF-immunopositive innervation
(Maule et al. 1990a, 1992a, b ; Marks et al. 1995).
NPF is also present in the peripheral nerve
plexuses associated with the reproductive structures
of ﬂatworms. For example, NPR-IR is rich in nerves
surrounding the muscular egg chambers of the im-
portant trematode parasites S. mansoni (Skuce et al.
1990;Marks et al. 1995) andF. hepatica (Magee et al.
1991; Marks et al. 1995). Much of the pathology
associated with these parasites is directly attributable
to the eggs, yet a great deal remains unknown
regarding the processes regulating egg production.
There are also special muscle groups associated with
the alimentary systems that include innervation
that displays NPF-IR. For example, the muscular
pharynx of the turbellarians P. littoralis (Reuter et al.
1995b) and Archiloa unipunctata (Reuter et al.
1995a) are heavily innervated, as is the oral sucker of
Table 3. Pre-propeptides enconding neuropeptide Fs in ﬂatworms
Species Pre-propeptide Sequence (Partial, Surrounding the Propeptide)
Moniezia expansa
Arthurdendyus triangulatus
… E S A Y V K R P D QD S I V N P S D L V L D NK A A L R D Y L R Q I N E Y F A I I GR P R F G *
…Y I N F S S V T V D AK V VH L R P R S S F S S E D E Y Q I Y L R N V S K Y I Q L YGR P R F G K R D L D R G…
…N N L S N I P N D Q Q R AQ A L AK LM S L F Y T S D A F NK YME N L D A Y YML RGR P R F G K R N Y N P I …
…N S N L N G P D E Q Q R AQ A L AK LMT L F Y T S D A F NK YME N L D A Y YML RGR P R F G K R N S Y H R …
D
L
F
Schistosoma mansoni
Schistosoma japonicum
The sequences displayed are only part of the pre-propeptides, centered on the portion that will produce the propeptides (in
bold face). The di- and mono-basic cleavage sites targeted by prohormone convertases (PCs) are boxed and have a white
background. Conversion of the propeptides to mature neuropeptides requires the conversion of the carboxy terminal
glycine (shaded in black) to an alpha-amide group. Residues conserved amongst the ﬂatworm NPFs are shaded gray, and
those conserved all NPFs and NPY family neuropeptides are shaded gray and boxed. References:A. triangulatus (Dougan
et al. 2002). S. mansoni and S. japonicum (Humphries et al. 2004).M. expansa (Mair et al. 2000a). *=stop codon.
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schistosomes (Skuce et al. 1990; Marks et al. 1995;
Mair et al. 1998).
Physiology/biochemistry of ﬂatworm NPFs
Even though the ﬁrst NPFs were identiﬁed over a
decade ago, and even though NPFs appear widely
distributed throughout the nervous systems of ﬂat-
worms and other invertebrates, there is still very
little known about the biological function of these
peptides in ﬂatworms or other invertebrates. The
localisation of NPFs could provide clues, suggesting
a role for the peptide in the modulation of somatic
muscle, reproduction and feeding. However, the
distribution of NPF is so broad that it eliminates few
possibilities.
There are data emerging that link NPF signalling
to a speciﬁc biochemical pathway, the inhibition of
cyclic AMP (cAMP) accumulation. Structural data
suggest a relationship between invertebrate NPFs
and vertebrate NPYs, and new functional data
also connect the peptides. NPY family peptides
act on a family of G protein-coupled receptors
(GPCRs) known collectively as Y receptors. All
ﬁve Y receptor subtypes have been linked to the
inhibition of adenylyl cyclase, and two of the
subtypes are also associated with increases in
cytoplasmic Ca2+ (Motulsky & Michel, 1988;
Mihara, Shigeri & Fujimoto, 1989; Aakerlund
et al. 1990). The inhibition of cAMP accumulation
is so regularly associated with Y receptors that it
has been called the universal signalling
mechanism for Y receptors (Michel, 1991; Michel
et al. 1998).
Two invertebrateGPCRs have been clonedwhich,
when in heterologous expression systems, respond to
NPFs; one is from Lymnaea stagnalis (Tensen et al.
1998) and one from Drosophila melanogaster
(Garczynski et al. 2002). Like receptors for ver-
tebrate NPYs, the invertebrate NPF receptors
produce an inhibition of cAMP accumulation, sug-
gesting that this signalling pathway could be con-
served betweenNPYs andNPFs. Amore compelling
case for linking invertebrate NPF receptors to the
inhibition of cAMP comes from schistosomes.
Schistosome NPF inhibits the accumulation of
cAMP in schistosome homogenates at a threshold of
10x11 M (Humphries et al. 2004). The inhibition is
quite speciﬁc, with the most potent action reserved
only for the endogenous schistosome peptide, but
could also be reproduced less potently by mxNPF
and porcine NPY. This potent and speciﬁc en-
dogenous inhibition of cAMP by NPF in an invert-
ebrate preparation is a more substantial link between
NPF-receptor signalling pathways in invertebrates
and those of vertebrate NPY family peptides. This
conservation of downstream signalling pathways
lends support to an evolutionary relationship be-
tween these peptides.
There are also data implicating NPF in ﬂatworm
muscle function. The earliest data suggesting that
NPF might act on muscle came from the myoexci-
tation observed when a truncated version of mxNPF
was applied to F. hepaticamuscle strips (Marks et al.
1996). Subsequently, mxNPF was found to be ex-
citatory on intact larvae of the cestode Mesocestoides
vogae at concentrations greater than 100 mM
(Hrcˇkova et al. 2004). Since M. vogae larval muscu-
lature is also stimulated by the cestode FLP
GNFFRFamide, it could be hypothesised that the
mxNPF myoexcitation is simply due to a rather in-
eﬃcient interaction with the excitatory muscle-based
FLP receptor. However, the FLP myoexcitation is
blocked by GNFFRdFamide and the mxNPF
myoexcitation is not, suggesting that they are inter-
acting with diﬀerent receptors. Although the high
concentration required could question the physio-
logical relevance of the ﬁndings, the large and polar
neuropeptide would not penetrate the whole animal
very eﬃciently providing a plausible reason for the
observed low potency.
The mxNPF-induced myoexcitation observed in
whole animals could be attributable to a muscle-
based receptor, but it could also be due toNPF eﬀects
on neuronal or other tissue. In fact, a number of di-
verse inhibitors blunted or blocked NPF’s myoex-
citation, including voltage-gated calcium channel
blockers, sarcoplasmic reticular calcium channel
blockers, calciumATPase inhibitors, PKC inhibitors
and even cAMP inhibitors. This suggests most par-
simoniously that NPF’s action on muscle is indirect
and depends on complex signalling interactions. The
studies did reveal that the NPF eﬀect involves a
GPCR and, contrary to expectations based on other
reports of NPF and NPY function, could include an
increase in cAMP levels (Hrcˇkova´ et al. 2004). Again,
this could be because an NPF receptor really is
directly coupled to a stimulation of cAMP, or it could
be that the cAMP occurs in the muscle as an indirect
result of NPFs action on another cell type or its non-
speciﬁc interaction with a Gs coupled receptor.
NPF summary
The structural similarities of ﬂatworm and mollus-
can NPFs leave little doubt of their relationship to
each other. However, the relationship between
invertebrate NPFs and vertebrate NPYs is still
unclear. The case for an evolutionary relationship
between invertebrate NPFs and vertebrate NPYs is
based on the following: (1.) The conservation of the
biologically-critical carboxy terminal, RXR(Y/F)-
amide. (2.) The conservation of tyrosine residues at
positions 10 and 17 relative to the carboxy terminus.
(3.) The conservation of size of the mature peptides,
most frequently 36 amino acids, always from 36–40
amino acids. (4.) The presence of a phase 2 intron in
the codon for the penultimate arginine inM. expansa
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NPF (Mair et al. 2000a). Phase 2 introns are in
themselves less common, and one can be found in the
codon for the penultimate arginine in vertebrate
NPY family peptides. (5.) The conservation of
downstream signalling pathways coupled to inhi-
bition of cAMP.
Although these data are somewhat compelling,
they are not conclusive. There does not appear to be a
phase 2 intron present in the genes forA. triangulatus
or schistosome NPFs (Dougan et al. 2002;
Humphries et al. 2004). The invertebrate peptides
also lack the conservation of prolines in a PXXPXXP
motif which is present in almost all vertebrate NPY
family peptides (although some of the NPFs feature
less organized prolines in the N-terminal half of the
peptide; see Table 3).
Despite some knowledge of the biochemical
pathways involved in NPF signalling and a potential
role inmusclemodulation, the physiological function
of NPF in ﬂatworms remains unresolved. One of the
major impediments to determining NPF function
has been a general lack of tissue or organ-based
bioassays. The active neuropeptide is quite polar
and, therefore, does not cross the surfaces of whole
animals very well at all, while most platyhelminth
bioassays utilize the whole animal. The elucidation of
NPF function in platyhelminths will almost certainly
require the development of new bioassays.
ELEMENTS COMMON TO FLP AND NPF
SIGNALLING SYSTEMS
Although neuropeptide receptors seem to be alluring
targets for new anthelmintic drugs, they are not the
only component of the neuropeptidergic systems
with such appeal. Neuropeptidergic transmission
requires more than simply the interaction of a pep-
tide signal with a receptor; both the generation of the
appropriate neuropeptides and the termination of the
neuropeptide signal present processes that are poten-
tially vulnerable to pharmacological interference.
Generation of neuropeptides
Rather than being enzymatically produced from
chemical precursors, neuropeptides are derived from
genetically encoded propeptides. The processing of
the original transcripts into mature signalling mol-
ecules requires a number of enzymatic steps (Fig. 1).
For example, a typical neuropeptide originates as a
pre-propeptide from which propeptides are cleaved
by prohormone convertases, and these propeptides,
which are glycine-extended intermediates, are en-
zymatically converted to amidated mature peptides.
Each of these two steps (1) the liberation of the
propeptide from the original transcript and (2) the
amidation of the propeptide to form active mature
neuropeptides, each represents potential targets for
disruption of the neuropeptidergic signalling sys-
tems that are vital to ﬂatworm biology. The speciﬁc
appeal of these targets is that they could represent a
site of vulnerability for all of the neuropeptide sig-
nalling systems in the worm.While interfering with a
single amidated neuropeptide by antagoinsing the
neuropeptide receptor could have important con-
sequences in the worm, blocking all amidated neuro-
peptide signalling by blocking the generation of
active peptides would likely be even more calamitous
…NNLSNIPNDQQRAQALAKLMSLFYTSDAFNKYMENLDAYYMLRGRPRFGKRNYNPI…
AQALAKLMSLFYTSDAFNKYMENLDAYYMLRGRPRFG
AQALAKLMSLFYTSDAFNKYMENLDAYYMLRGRPRFamide
Mature Neuropeptide
Propeptide
Pre-Propeptide
PC
PHM
PAL
PC
Fig. 1. Schematic of the enzymatic processing involved in the production of mature, bioactive amidated neuropeptides
in ﬂatworms. The schematic uses the Schistosoma mansoni NPF sequence as an example (Humphries et al. 2004).
Prohormone convertases (PC) clip the pre-propeptide at mono- and di-basic sites to form the glycine-extended
propeptide. Although the N-terminus of neuropeptides can be produced by cleavage of the signal peptide, three of the
four ﬂatworm peptides in which the pre-propeptide structure is known appear to have the N-terminus formed by PC
cleavage (see Table 3). The only case in which PC cleavage does not produce the carboxy terminus of the glycine-
extended propeptide isM. expansa NPF (Mair et al. 2000a) where a stop codon follows the codon for glycine, such that
the original translated product requires no cleavage. The carboxy-terminal glycine is then converted to a more stable
a-amide group by the sequential action of peptidyl a-hydroxylating monooxygenase (PHM) and peptidyl
a-hydroxyglycine a-amidating lyase (PAL). This is the only known mechanism for producing a-amidation, and
neurally-distributed PHMs have been identiﬁed in schistosomes (Mair et al. 2004) and planaria (Asada et al. 2005).
Neuropeptides in ﬂatworms S49
to the parasite. However, a major hurdle for the ex-
ploitation of these potential targets would be selec-
tivity, since the enzymes responsible forneuropeptide
processing in the parasites could be very similar to
those performing the same function in the host.
Prohormone convertases. The prohormone con-
vertase (PC) gene family is widespread throughout
the phyla, from prokaryotes to eukaryotes and,
because the catalytic domain is highly conserved, all
PCs are thought to have originated from a common
gene (Seidah et al. 1998). The only direct evidence
for a PC in platyhelminths is from the free-living
Dugesia japonica where a cDNA encoding a PC2
homologue has been characterized which is 67%
similar to the Aplysia PC2 (Agata et al. 1998).
Although there have been no functional studies on
the D. japonica PC2, in situ hybridization shows it to
be distributed throughout the CNS – in fact, it is
used as a CNS-speciﬁc marker to track CNS regen-
eration (Agata et al. 1998).
There is a great deal of indirect evidence for
functional PCs in platyhelminths. Most convinc-
ingly, the parent pre-propeptides of some platy-
helminth neuropeptides are known and the resultant
mature peptides demonstrate cleavage at the same
mono- and di-basic sites typically targeted by PCs.
For example, the sequences ofM. expansa (Mair et al.
2000a), Arthurdendyus triangulatus (Dougan et al.
2002) and S. mansoni (Humphries et al. 2004) pre-
proNPFs are known, and production of the known
proNPFs requires cleavage at signature basic sites.
Further, a search of platyhelminth sequences reveals
a number of other potential convertase sequences
within the phylum, but there are as yet no functional
data. However, experimental evidence from the
model platyhelminth Schmidtea mediterranea sup-
ports the importance of PCs in ﬂatworms. These
planarians feature a cDNA encoding a protein most
similar to PCs in the molluscs L. stagnalis (Smit,
Spijker & Geraerts, 1992) and Aplysia californica
(Ouimet et al. 1994). RNAi-mediated silencing of
that S. mediterranea gene produces worms with
motility defects, including paralysis (Reddien et al.
2005). Since neuropeptides putatively processed by
PCs are known to be myoexcitatory in a number of
ﬂatworms, deletion of PCs might be expected to
produce motor defects.
In summary, although there is compelling evi-
dence for the presence and biological importance of
PCs in ﬂatworms, at this time very little is known
about the speciﬁc nature of these enzymes within the
phylum. Certainly, not enough is known to speculate
as to whether pharmacological diﬀerences between
host and parasite PCs could be suﬃcient for phar-
macological exploitation.
Amidating enzymes. Most mammalian and insect
neuropeptides and hormones feature an alpha amide
group at the carboxy terminus. This alpha amide
group is generated by the post-translational modiﬁ-
cation of a C-terminal glycine-extended propeptide,
and the process includes two sequential reactions;
the ﬁrst is catalysed by peptidyl a-hydroxylating
monooxygenase (PHM) and the second is catalysed
by peptidyl a-hydroxyglycine a-amidating lyase
(PAL). PHM and PAL are two separate catalytic
moieties but, in many eukaryotes, both exist on a
single bifunctional protein called peptidylglycine
a-amidating monoxygenase (PAM) (Eipper, Stoﬀers
& Mains, 1992; Eipper et al. 1993). In some in-
vertebrates such asDrosophila, Calliactis andHydra,
PHM and PAL are expressed as independent pro-
teins (Hauser, Williamson & Grimmelikhuijzen,
1997; Kolhekar et al. 1997; Williamson, Hauser &
Grimmelikhuijzen, 2000). The end result of the two
reactions is the conversion of the ionisable free
carboxylic acid on the carboxy terminus of the pro-
peptide to a non-ionisable alpha amide group. The
carboxy-terminal amidation is usually essential for
the bioactivity of these peptides (Prigge et al. 2000).
The presence of these amidating enzymes in ﬂat-
worms is testiﬁed to by the number of amidated
neuropeptides that have already been structurally
characterized from the phylum. As described earlier,
the ﬁrst such ﬂatworm neuropeptide wasM. expansa
NPF, which ends with the signature motif
GRPRFamide (the amide group can be represented
biochemically as –NH2, in this review the ‘amide’
notation is used) (Maule et al. 1991). Later, A. tri-
angulatus NPF, GNFFRFamide, RYIRFamide,
YIRFamide and GYIRFamide were structurally
characterized from platyhelminths. In all of these
cases, the mature peptides were not predicted from
molecular data, rather the neuropeptides were
puriﬁed and structurally characterized. The presence
of these amidated carboxy termini on endogenous
peptides is indication of the presence of amidating
enzymes in the worms.
The importance of the amidation reaction to the
function of these neuropeptides in ﬂatworms is evi-
dent from physiological data; the absence of the
amide group renders both the FLPs and the NPFs
inactive. The potent myoactivity of FLPs on
schistosome muscle is abolished in the absence of the
carboxy-terminal amide (Day et al. 1997). For ex-
ample, YIRFamide has a half-eﬀective concentration
of 4 nM, while the YIRF lacking the amidation is
completely without eﬀect. Likewise, while porcine
NPY can mimic schistosome NPF’s inhibition of
cAMP in worm homogenates, a non-amidated por-
cine NPY is without eﬀect (Humphries et al. 2004).
There is now direct evidence for the presence of
amidating enzymes in ﬂatworms; the enzyme which
catalyses the ﬁrst step has been identiﬁed in
S. mansoni (Mair et al. 2004) and named smPHM.
The enzyme is widely distributed throughout the
schistosome nervous system, including both the
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central and peripheral nervous system. In this
regard, the smPHM immunoreactivity looks much
like the staining observed with antisera targeting
FLPs and NPFs. In fact, immunoreactivity for the
amidating enzyme appeared even more widespread
than that observed for FLPs and NPF – suggesting
that some neurones negative for FLPs and NPFs
may express PHM and, therefore, other as yet-
unidentiﬁed amidated neuropeptides. Another PHM
has recently been identiﬁed in the free-living platy-
helminth Dugesia japonicum (Asada et al. 2005) ; in
this planarian, PHM is also localised to the nervous
system.
Heterologously expressed schistosome PHM has
functional PHM activity, but it also has some
characteristics diﬀerent from typical PHMs. For
example, one requirement for PHM activity is Cu2+
and both schistosome and rat PHM lose activity
when the available Cu2+ is chelated by EDTA.
However, while other PHMs are dramatically in-
hibited by the absence of exogenous (0.5–1.0 mM)
Cu2+, smPHM is not signiﬁcantly inhibited, sug-
gesting that the schistosome enzyme more avidly
binds Cu2+. Also unlike other previously described
PHMs, smPHMhas little activity at neutral pH, with
optimal activity at pH 3.5. Lastly, the schistosome
enzyme showed a 10-foldKm greater compared to rat
PHM for the peptidylglycine substrate. Although
the functional signiﬁcance of these diﬀerences
between schistosome PHM and its mammalian
homologues are unclear, the diﬀerences do suggest
that there could be exploitable pharmacological
diﬀerences between the host and parasite enzymes.
CONCLUSIONS
There is a great deal of recent evidence for the cen-
trality of neuropeptides in the biology of parasitic
ﬂatworms. In common with each other, both NPFs
and FLPs are very broadly expressed and conserved
across ﬂatworms suggesting fundamental roles in
platyhelminth biology. Accepting this fundamental
similarity, the contrast in comparative relationships
between the two known neuropeptide messengers in
ﬂatworms and those in vertebrates could not be more
stark. The FLPs form a signalling system that
appears to be pivotal to co-ordinated motor function
in ﬂatworms and yet in vertebrates these peptides are
very sparsely expressed and appear to be of limited
functional signiﬁcance with no known role in motor
co-ordination. In complete contrast, the NPFs
appear to be homologous to the most abundant
neuropeptide in vertebrate brains, namely NPY, and
to employ the same second messenger pathway to
convey their cytosolic signals. Notwithstanding this
contrast, they both are structurally quite distinct
from known vertebrate neuropeptides – elevating the
attraction of their receptors as novel targets for
parasite control.
Although it is highly likely that other neuropeptide
families occur within ﬂatworms, until their dis-
covery, the focus must remain on FLPs and NPFs.
Indeed, the signalling systems associated with FLPs
and NPFs in parasitic ﬂatworms each have appeal as
potential reservoirs of chemotherapeutic targets. In
both cases, it seems likely that the receptors for the
neuropeptides are the foremost candidates as novel
anthelmintic targets, but there is presently very little
known about these receptors. There is now a con-
vergence of factors that should, in the near future,
precipitate a harvest of knowledge regarding these
receptors and other components of neuropeptide
signalling. Firstly, the rapidly emerging genomic and
EST data from ﬂatworms will be of immense value in
uncovering novel proteins and peptides.
Coincidentally, the recent discovery of a number
of neuropeptide receptors from other invertebrates
will inform homology searches of the new genetic
data from platyhelminths (see Greenwood, Williams
and Geary in this supplement). Lastly, assays to
characterize, functionally express and screen newly
discovered receptors are rapidly increasing in both
ease and sophistication. Although the neuropeptide
receptorsmay be themost obvious target, others hold
promise as well. If neuropeptide processing enzymes
such as prohormone convertases and amidating
enzymes prove to have suﬃcient pharmacological
distinctions from their mammalian homologues,
these could be prime targets for drugs that would
compromise the biology of parasitic platyhelminths.
ACKNOWLEDGEMENTS
The authors are supported by NIH Grant AI49162.
REFERENCES
AAKERLUND, L., GETHER, U., FUHLENDORFF, J.,
SCHWARTZ, T. W. & THASTRUP, O. (1990). Y1 receptors for
neuropeptide Y are coupled to mobilization of
intracellular calcium and inhibition of adenylate cyclase.
FEBS Letters 260, 73–78.
AGATA, K., SOEJIMA, Y., KATO, K., KOBAYASHI, C.,
UMESONO, Y. & WATANABE, K. (1998). Structure of the
planarian central nervous system (CNS) revealed by
neuronal cell markers. Zoological Science 15, 433–440.
ARMSTRONG, E. P., HALTON, D. W., TINSLEY, R. C., CABLE, J.,
JOHNSTON, R. N., JOHNSTON, C. F. & SHAW, C. (1997).
Immunocytochemical evidence for the involvement of
an FMRFamide-related peptide in egg production in the
ﬂatworm parasite Polystoma nearcticum. Journal of
Comparative Neurology 377, 41–48.
ASADA, A., ORII, H., WATANABE, K. & TSUBAKI, M. (2005).
Planarian peptidylglycine-hydroxylating
monooxygenase, a neuropeptide processing enzyme,
colocalizes with cytochrome b561 along the central
nervous system. FEBS Journal 272, 942–955.
BALASUBRAMANIAM, A. (1997). Neuropeptide Y family of
hormones: receptor subtypes and antagonists. Peptides
18, 445–457.
Neuropeptides in ﬂatworms S51
BALASUBRAMANIAM, A. (2003). Neuropeptide Y (NPY)
family of hormones: progress in the development of
receptor selective agonists and antagonists. Current
Pharmaceutical Design 9, 1165–1175.
BISEROVA, N. M., DUDICHEVA, V. A., TERENINA, N. B.,
REUTER, M., HALTON, D. W., MAULE, A. G. &
GUSTAFSSON, M. K. (2000). The nervous system of
Amphilina foliacea (Platyhelminthes, Amphilinidea).
An immunocytochemical, ultrastructural and
spectroﬂuorometrical study. Parasitology 121, 441–453.
BLAIR, K. & ANDERSON, P. (1994). Physiological and
pharmacological properties muscle cells isolated from
the ﬂatworm Bdelloura candida. Parasitology 109,
325–335.
BLAIR, K. L., BENNETT, J. L. & PAX, R. A. (1988). Schistosoma
mansoni : evidence for protein kinase-C-like modulation
of muscle activity. Experimental Parasitology 66,
243–252.
BLAIR, K. L., DAY, T. A., LEWIS, M. C., BENNETT, J. L. &
PAX, R. A. (1991). Studies on muscle cells isolated from
Schistosoma mansoni : a Ca2+-dependent K+ channel.
Parasitology 102, 251–258.
BOYLE, J. P., WU, X. J., SHOEMAKER, C. B. & YOSHINO, T. P.
(2003). Using RNA interference to manipulate
endogenous gene expression in Schistosoma mansoni
sporocysts.Molecular and Biochemical Parasitology 128,
205–215.
CABLE, J., MARKS, N. J., HALTON, D. W., SHAW, C.,
JOHNSTON, C. F., TINSLEY, R. C. & GANNICOTT, A. M.
(1996). Cholinergic, serotoninergic and peptidergic
components of the nervous system of Discocotyle
sagittata (Monogenea: Polyopisthocotylea).
International Journal for Parasitology 26, 1357–1367.
CHANCE, M. R. & MANSOUR, T. E. (1949). A kymographic
study of the action of drugs on the liver ﬂuke
(Fasciola hepatica). British Journal of Pharmacology 4,
7–13.
CHANCE, M. R. & MANSOUR, T. E. (1953). A contribution to
the pharmacology of movement in the liver ﬂuke.British
Journal of Pharmacology 8, 134–138.
COBBETT, P. & DAY, T. A. (2003). Functional voltage-gated
Ca2+ channels in muscle ﬁbers of the platyhelminth
Dugesia tigrina. Comparative Biochemistry and
Physiology. Part A,Molecular and Integrative Physiology
134, 593–605.
CURRY, W. J., SHAW, C., JOHNSTON, C. F., THIM, L. &
BUCHANAN, K. D. (1992). Neuropeptide F: primary
structure from the tubellarian, Artioposthia triangulata.
Comparative Biochemistry and Physiology. C:
Comparative Pharmacology 101, 269–274.
DAVIS, R. E. & STRETTON, A. O. (1996). The motornervous
system of Ascaris : electrophysiology and anatomy of the
neurons and their control by neuromodulators.
Parasitology 113 (Suppl.), S97–S117.
DAY, T. A., BENNETT, J. L. & PAX, R. A. (1994). Serotonin and
its requirement for maintenance of contractility in
muscle ﬁbres isolated from Schistosoma mansoni.
Parasitology 108, 425–432.
DAY, T. A., HAITHCOCK, J., KIMBER, M. & MAULE, A. G. (2000).
Functional ryanodine receptor channels in ﬂatworm
muscle ﬁbres. Parasitology 120, 417–422.
DAY, T. A. & MAULE, A. G. (1999). Parasitic peptides! The
structure and function of neuropeptides in parasitic
worms. Peptides 20, 999–1019.
DAY, T. A., MAULE, A. G., SHAW, C., HALTON, D. W., MOORE, S.,
BENNETT, J. L. & PAX, R. A. (1994). Platyhelminth
FMRFamide-related peptides (FaRPs) contract
Schistosoma mansoni (Trematoda: Digenea) muscle
ﬁbres in vitro. Parasitology 109, 455–459.
DAY, T. A., MAULE, A. G., SHAW, C. & PAX, R. A. (1997).
Structure-activity relationships of FMRFamide-related
peptides contracting Schistosoma mansoni muscle.
Peptides 18, 917–921.
DOUGAN, P. M., MAIR, G. R., HALTON, D. W., CURRY, W. J.,
DAY, T. A. & MAULE, A. G. (2002). Gene organization and
expression of a neuropeptide Y homolog from the land
planarian Arthurdendyus triangulatus. Journal of
Comparative Neurology 454, 58–64.
EIPPER, B. A., MILGRAM, S. L., HUSTEN, E. J., YUN, H. Y. &
MAINS, R. E. (1993). Peptidylglycine alpha-amidating
monooxygenase: a multifunctional protein with
catalytic, processing, and routing domains. Protein
Science 2, 489–497.
EIPPER, B. A., STOFFERS, D. A. & MAINS, R. E. (1992). The
biosynthesis of neuropeptides: peptide alpha-amidation.
Annual Review of Neuroscience 15, 57–85.
EL-SAYED, N. M., BARTHOLOMEU, D., IVENS, A.,
JOHNSTON, D. A. & LOVERDE, P. T. (2004). Advances in
schistosome genomics. Trends in Parasitology 20,
154–157.
ESPINOZA, E., CARRIGAN, M., THOMAS, S. G., SHAW, G. &
EDISON, A. S. (2000). A statistical view of FMRFamide
neuropeptide diversity.Molecular Neurobiology 21,
35–56.
GARCZYNSKI, S. F., BROWN, M. R., SHEN, P., MURRAY, T. F. &
CRIM, J. W. (2002). Characterization of a functional
neuropeptide F receptor from Drosophila melanogaster.
Peptides 23, 773–780.
GONZALEZ-ESTEVEZ, C., MOMOSE, T., GEHRING, W. J. &
SALO, E. (2003). Transgenic planarian lines obtained by
electroporation using transposon-derived vectors and an
eye-speciﬁc GFP marker. Proceedings of the National
Academy of Sciences, USA 100, 14046–14051.
GRAHAM, M. K., FAIRWEATHER, I. & MCGEOWN, J. G. (1997).
The eﬀects of FaRPs on the motility of isolated muscle
strips from the liver ﬂuke,Fasciola hepatica.Parasitology
114, 455–465.
GRAHAM, M. K., FAIRWEATHER, I. & MCGEOWN, J. G. (2000).
Second messengers mediating mechanical responses to
the FARP GYIRFamide in the ﬂuke Fasciola hepatica.
American Journal of Physiology, Regulatory Integrative
and Comparative Physiology 279, R2089–R2094.
GRAHAM, M. K., MCGEOWN, J. G. & FAIRWEATHER, I. (1999).
Ionic mechanisms underlying spontaneous muscle
contractions in the liver ﬂuke, Fasciola hepatica.
American Journal of Physiology 277, R374–R383.
GREENBERG, M. J., PAYZA, K., NACHMAN, R. J., HOLMAN, G. M.
& PRICE, D. A. (1988). Relationships between the
FMRFamide-related peptides and other peptide
families. Peptides 9, 125–135.
HALTON, D. W. & GUSTAFSSON, M. K. S. (1996). Functional
morphology of the platyhelminth nervous system.
Parasitology 113 (Suppl.), S47–S72.
HALTON, D. W. & MAULE, A. G. (2004). Flatworm nerve-
muscle: structural and functional analysis. Canadian
Journal of Zoology 82, 316–333.
HAUSER, F., WILLIAMSON, M. & GRIMMELIKHUIJZEN, C. J.
(1997). Molecular cloning of a peptidylglycine
P. McVeigh and others S52
alpha-hydroxylating monooxygenase from sea
anemones. Biochemical and Biophysical Research
Communications 241, 509–512.
HEYERS, O., WALDUCK, A. K., BRINDLEY, P. J., BLEISS, W.,
LUCIUS, R., DORBIC, T., WITTIG, B. & KALINNA, B. H. (2003).
Schistosoma mansoni miracidia transformed by particle
bombardment infect Biomphalaria glabrata snails and
develop into transgenic sporocysts. Experimental
Parasitology 105, 174–178.
HRCˇKOVA´, G., VELEBNY, S., HALTON, D. W., DAY, T. A. &
MAULE, A. G. (2004). Pharmacological characterisation of
neuropeptide F (NPF)-induced eﬀects on the motility of
Mesocestoides corti (syn.Mesocestoides vogae) larvae.
International Journal for Parasitology 34, 83–93.
HUMPHRIES, J. E., KIMBER, M. J., BARTON, Y. W., HSU, W.,
MARKS, N. J., GREER, B., HARRIOTT, P., MAULE, A. G. &
DAY, T. A. (2004). Structure and bioactivity of
neuropeptide F from the human parasites Schistosoma
mansoni and Schistosoma japonicum. Journal of Biological
Chemistry 279, 39880–39885.
HUMPHRIES, J. E., MOUSLEY, A., MAULE, A. G. & HALTON, D. W.
(2000). Neuromusculature structure and functional
correlates. In Echinostomes as Experimental Models for
Biological Research (eds B. Fried & T. K. Graczyk), pp.
213–227. Kluwer Academic Publishers, Dordrecht, The
Netherlands.
JOHNSTON, R. N., SHAW, C., BRENNAN, G. P., MAULE, A. G. &
HALTON, D. W. (1995a). Localisation, quantitation, and
characterisation of neuropeptide F- and FMRFamide-
immunoreactive peptides in turbellarians and a
monogenean: a comparative study. Journal of
Comparative Neurology 357, 76–84.
JOHNSTON, R. N., SHAW, C., HALTON, D. W., VERHAERT, P. &
BAGUNA, J. (1995b). GYIRFamide: a novel
FMRFamide-related peptide (FaRP) from the triclad
turbellarian, Dugesia tigrina. Biochemical and
Biophysical Research Communications 209, 689–697.
JOHNSTON, R. N., SHAW, C., HALTON, D. W., VERHAERT, P.,
BLAIR, K. L., BRENNAN, G. P., PRICE, D. A. &
ANDERSON, P. A. V. (1996). Isolation, localization, and
bioactivity of the FMRFamide-related neuropeptides
GYIRFamide and YIRFamide from the marine
turbellarian Bdelloura candida. Journal of
Neurochemistry 67, 814–821.
KIM, K. & LI, C. (2004). Expression and regulation of an
FMRFamide-related neuropeptide gene family in
Caenorhabditis elegans. Journal of Comparative
Neurology 475, 540–550.
KOLHEKAR, A. S., KEUTMANN, H. T., MAINS, R. E., QUON, A. S.
& EIPPER, B. A. (1997). Peptidylglycine alpha-
hydroxylating monooxygenase: active site residues,
disulﬁde linkages, and a two-domain model of the
catalytic core. Biochemistry 36, 10901–10909.
KOTIKOVA, E. A., RAIKOVA, O. I., REUTER, M. &
GUSTAFSSON, M. K. (2002). The nervous and muscular
systems in the free-living ﬂatworm Castrella truncata
(Rhabdocoela) : an immunocytochemical and phalloidin
ﬂuorescence study. Tissue and Cell 34, 365–374.
KUMAR, D., MCGEOWN, J. G., REYNOSO-DUCOING, O.,
AMBROSIO, J. R. & FAIRWEATHER, I. (2003). Observations
on the musculature and isolated muscle ﬁbres of the liver
ﬂuke, Fasciola hepatica. Parasitology 127, 457–473.
KUMAR, D., WHITE, C., FAIRWEATHER, I. & MCGEOWN, J. G.
(2004). Electrophysiological and pharmacological
characterization of K+-currents in muscle ﬁbres isolated
from the ventral sucker ofFasciola hepatica.Parasitology
129, 779–793.
LARHAMMAR, D. (1996). Evolution of neuropeptide Y,
peptide YY and pancreatic polypeptide. Regulatory
Peptides 62, 1–11.
LI, C., KIM, K. & NELSON, L. S. (1999). FMRFamide-related
neuropeptide gene family in Caenorhabditis elegans.
Brain Research 848, 26–34.
LOVERDE, P. T., HIRAI, H., MERRICK, J. M., LEE, N. H. &
EL-SAYED, N. (2004). Schistosoma mansoni genome
project : an update. Parasitology International 53,
183–192.
MAGEE, R. M., FAIRWEATHER, I., SHAW, C., MCKILLOP, J. M.,
MONTGOMERY, W. I., JOHNSTON, C. F. & HALTON, D. W.
(1991). Quantiﬁcation and partial characterisation of
regulatory peptides in the liver ﬂuke, Fasciola hepatica,
from diﬀerent mammalian hosts. Comparative
Biochemistry and Physiology. C: Comparative
Pharmacology 99, 201–207.
MAIR, G. R., HALTON, D. W., SHAW, C. & MAULE, A. G.
(2000a). The neuropeptide F (NPF) encoding gene
from the cestode,Moniezia expansa. Parasitology 120,
71–77.
MAIR, G. R., MAULE, A. G., DAY, T. A. & HALTON, D. W.
(2000b). A confocal microscopical study of the
musculature of adult Schistosoma mansoni. Parasitology
121, 163–170.
MAIR, G. R., MAULE, A. G., SHAW, C. & HALTON, D. W. (1998).
Muscling in on parasitic ﬂatworms. Parasitology Today
14, 73–76.
MAIR, G. R., NICIU, M. J., STEWART, M. T., BRENNAN, G.,
OMAR, H., HALTON, D. W., MAINS, R., EIPPER, B. A.,
MAULE, A. G. & DAY, T. A. (2004). A functionally atypical
amidating enzyme from the human parasite Schistosoma
mansoni. FASEB Journal 18, 114–121.
MARKS, N. J., HALTON, D. W., MAULE, A. G., BRENNAN, G. P.,
SHAW, C., SOUTHGATE, V. R. & JOHNSTON, C. F. (1995).
Comparative analyses of the neuropeptide F (NPF)- and
FMRFamide-related peptide (FaRP)-
immunoreactivities in Fasciola hepatica and Schistosoma
spp. Parasitology 110, 371–381.
MARKS, N. J., JOHNSON, S., MAULE, A. G., HALTON, D. W.,
SHAW, C., GEARY, T. G., MOORE, S. & THOMPSON, D. P.
(1996). Physiological eﬀects of platyhelminth RFamide
peptides on muscle-strip preparations of Fasciola
hepatica (Trematoda: Digenea). Parasitology 113,
393–401.
MATZ, M. (2002). Ampliﬁcation of representative cDNA
samples frommicroscopic amounts of invertebrate tissue
to search for new genes.Methods in Molecular Biology
183, 3–18.
MATZ, M. (2003). Ampliﬁcation of representative cDNA
pools from microscopic amounts of animal tissue.
Methods in Molecular Biology 221, 103–116.
MAULE, A. G., BRENNAN, G. P., HALTON, D. W., SHAW, C.,
JOHNSTON, C. F. & MOORE, S. (1992b). Neuropeptide
F-immunoreactivity in the monogenean parasite
Diclidophora merlangi. Parasitology Research 78,
655–660.
MAULE, A. G., HALTON, D. W., ALLEN, J. & FAIRWEATHER, I.
(1989b). Studies on motility in vitro of an ectoparasitic
monogenean, Diclidophora merlangi. Parasitology 98,
85–93.
Neuropeptides in ﬂatworms S53
MAULE, A. G., HALTON, D. W., JOHNSTON, C. F.,
FAIRWEATHER, I. & SHAW, C. (1989a).
Immunocytochemical demonstration of neuropeptides
in the ﬁsh-gill parasite, Diclidophora merlangi
(Monogenoidea). International Journal for Parasitology
19, 307–316.
MAULE, A. G., HALTON, D. W., JOHNSTON, C. F., SHAW, C. &
FAIRWEATHER, I. (1990a). The serotoninergic,
cholinergic and peptidergic components of the nervous
system in the monogenean parasite, Diclidophora
merlangi : a cytochemical study. Parasitology 100,
255–273.
MAULE, A. G., HALTON, D. W., JOHNSTON, C. F., SHAW, C. &
FAIRWEATHER, I. (1990b). A cytochemical study of the
serotoninergic, cholinergic and peptidergic components
of the reproductive system in the monogenean parasite,
Diclidophora merlangi. Parasitology Research 76,
409–419.
MAULE, A. G., HALTON, D. W. & SHAW, C. (1995).
Neuropeptide F: a ubiquitous invertebrate
neuromediator? Hydrobiologia 305, 297–303.
MAULE, A. G., HALTON, D. W., SHAW, C. & JOHNSTON, C. F.
(1993a). The cholinergic, serotoninergic and peptidergic
components of the nervous system ofMoniezia
expansa (Cestoda, Cyclophyllidea). Parasitology 106,
429–440.
MAULE, A. G., MOUSLEY, A., MARKS, N. J., DAY, T. A.,
THOMPSON, D. P., GEARY, T. G. & HALTON, D. W. (2002).
Neuropeptide signaling systems – potential drug targets
for parasite and pest control.Current Topics inMedicinal
Chemistry 2, 733–758.
MAULE, A. G., SHAW, C., HALTON, D. W., BRENNAN, G. P.,
JOHNSTON, C. F. & MOORE, S. (1992a). Neuropeptide F
(Moniezia expansa) : localization and characterization
using speciﬁc antisera. Parasitology 105, 505–512.
MAULE, A. G., SHAW, C., HALTON, D. W., CURRY, W. J. &
THIM, L. (1994). RYIRFamide: a turbellarian
FMRFamide-related peptide (FaRP). Regulatory
Peptides 50, 37–43.
MAULE, A. G., SHAW, C., HALTON, D. W. & THIM, L. (1993b).
GNFFRFamide: a novel FMRFamide-immunoreactive
peptide isolated from the sheep tapeworm, Moniezia
expansa. Biochemical and Biophysical Research
Communications 193, 1054–1060.
MAULE, A. G., SHAW, C., HALTON, D. W., THIM, L.,
JOHNSTON, C. F., FAIRWEATHER, I. & BUCHANAN, K. D.
(1991). Neuropeptide F: a novel parasitic ﬂatworm
regulatory peptide fromMoniezia expansa (Cestoda:
Cyclophyllidea). Parasitology 102, 309–316.
MCVEIGH, P., LEECH, S., MAIR, G. R., MARKS, N. J., GEARY, T. G.
& MAULE, A. G. (2005). Analysis of FMRFamide-like
peptide (FLP) diversity in phylum Nematoda.
International Journal for Parasitology 35, 1043–1060.
MICHEL, M. C. (1991). Receptors for neuropeptide Y:
multiple subtypes and multiple second
messengers. Trends in Pharmacological Sciences 12,
389–394.
MICHEL, M. C., BECK-SICKINGER, A., COX, H., DOODS, H. N.,
HERZOG, H., LARHAMMAR, D., QUIRION, R., SCHWARTZ, T. &
WESTFALL, T. (1998). XVI International Union of
Pharmacology recommendations for the nomenclature
of neuropeptide Y, peptide YY, and pancreatic
polypeptide receptors. Pharmacological Reviews 50,
143–150.
MIHARA, S., SHIGERI, Y. & FUJIMOTO, M. (1989).
Neuropeptide Y-induced intracellular Ca2+ increases in
vascular smooth muscle cells. FEBS Letters 259, 79–82.
MONEYPENNY, C. G., KRESHCHENKO, N., MOFFETT, C. L.,
HALTON, D. W., DAY, T. A. & MAULE, A. G. (2001).
Physiological eﬀects of FMRFamide-related peptides
and classical transmitters on dispersed muscle ﬁbres of
the turbellarian, Procerodes littoralis. Parasitology 122,
447–455.
MONEYPENNY, C. G., MAULE, A. G., SHAW, C., DAY, T. A.,
PAX, R. A. & HALTON, D. W. (1997). Physiological eﬀects of
platyhelminth FMRF amide-related peptides (FaRPs)
on the motility of the monogenean Diclidophora
merlangi. Parasitology 115, 281–288.
MOTULSKY, H. J. & MICHEL, M. C. (1988). Neuropeptide Y
mobilizes Ca2+ and inhibits adenylate cyclase in human
erythroleukemia cells. American Journal of Physiology
255, E880–E885.
MOUSLEY, A., MARKS, N. J., HALTON, D. W., GEARY, T. G.,
THOMPSON, D. P. & MAULE, A. G. (2004). Arthropod
FMRFamide-related peptides modulate muscle activity
in helminths. International Journal for Parasitology 34,
755–768.
NOEL, F., CUNHA, V. M., SILVA, C. L. & MENDONCA-SILVA, D. L.
(2001). Control of calcium homeostasis in Schistosoma
mansoni.Memorias do Instituto Oswaldo Cruz 96S,
85–88.
OUIMET, T., MAMMARBACHI, A., CLOUTIER, T., SEIDAH, N. G. &
CASTELLUCI, V. F. (1994). cDNA structure and in situ
localization of the Aplysia californica pro-hormone
convertase PC2. FEBS Letters 337, 119–120.
PAASONEN, M. K. & VARTIAINEN, A. (1958). Pharmacological
studies on the body wall musculature of cat tapeworm
(Taenia taeniaeformis). Acta Pharmacologica et
Toxicologica 15, 29–36.
PIERCE, S. B., COSTA, M., WISOTZKEY, R., DEVADHAR, S.,
HOMBURGER, S. A., BUCHMAN, A. R., FERGUSON, K. C.,
HELLER, J., PLATT, D. M., PASQUINELLI, A. A., LIU, L. X.,
DOBERSTEIN, S. K. & RUVKUN, G. (2001). Regulation of
DAF-2 receptor signaling by human insulin and ins-1, a
member of the unusually large and diverse C. elegans
insulin gene family.Genes and Development 15, 672–686.
PRICE, D. A. & GREENBERG, M. J. (1977). Structure of a
molluscan cardioexcitatory neuropeptide. Science 197,
670–671.
PRIGGE, S. T., MAINS, R. E., EIPPER, B. A. & AMZEL, L. M.
(2000). New insights into copper monooxygenases and
peptide amidation: structure, mechanism and function.
Cellular and Molecular Life Sciences 57, 1236–1259.
REDDIEN, P. W., BERMANGE, A. L., MURFITT, K. J.,
JENNINGS, J. R. & SANCHEZ ALVARADO, A. (2005).
Identiﬁcation of genes needed for regeneration, stem
cell function, and tissue homeostasis by systematic
gene perturbation in planaria. Developmental Cell 8,
635–649.
REUTER, M., GUSTAFSSON, M. K., SAHLGREN, C., HALTON,
D. W., MAULE, A. G. & SHAW, C. (1995b). The nervous
system of Tricladida. I. Neuroanatomy of Procerodes
littoralis (Maricola, Procerodidae) : an
immunocytochemical study. Invertebrate Neuroscience 1,
113–122.
REUTER, M., MAULE, A. G., HALTON, D. W.,
GUSTAFSSON, M. K. S. & SHAW, C. (1995a). The
organization of the nervous system in Platyhelminthes.
P. McVeigh and others S54
The neuropeptide F-immunoreactive pattern in
Catenulida, Macrostomida, Proseriata. Zoomorphology
115, 83–97.
SAMII, S. I. & WEBB, R. A. (1996). The stimulatory eﬀect of
L-glutamate and related agents on inositol 1,4,5-
trisphosphate production in the cestode Hymenolepis
diminuta. Comparative Biochemistry and Physiology.Part
C, Pharmacology, Toxicology and Endocrinology 113,
409–420.
SANCHEZ ALVARADO, A., NEWMARK, P. A., ROBB, S. M. &
JUSTE, R. (2002). The Schmidtea mediterranea database
as a molecular resource for studying platyhelminthes,
stem cells and regeneration. Development 129,
5659–5665.
SˇEBELOVA´, S., STEWART, M. T., MOUSLEY, A., FRIED, B.,
MARKS, N. J. & HALTON, D. W. (2004). The musculature
and associated innervation of adult and intramolluscan
stages of Echinostoma caproni (Trematoda) visualised
by confocal microscopy. Parasitology Research 93,
196–206.
SEIDAH, N. G., DAY, R., MARCINKIEWICZ, M. & CHRETIEN, M.
(1998). Precursor convertases: an evolutionary ancient,
cell-speciﬁc, combinatorial mechanism yielding diverse
bioactive peptides and proteins. Annals of the New York
Academy of Sciences 839, 9–24.
SHAW, C., MAULE, A. G. & HALTON, D. W. (1996).
Platyhelminth FMRFamide-related peptides.
International Journal for Parasitology 26, 335–345.
SKELLY, P. J., DA’DARA, A. & HARN, D. A. (2003). Suppression
of cathepsin B expression in Schistosoma mansoni by
RNA interference. International Journal for Parasitology
33, 363–369.
SKUCE, P. J., JOHNSTON, C. F., FAIRWEATHER, I.,
HALTON, D. W., SHAW, C. & BUCHANAN, K. D. (1990).
Immunoreactivity to the pancreatic polypeptide family
in the nervous system of the adult human blood ﬂuke,
Schistosoma mansoni. Cell and Tissue Research 261,
573–581.
SMIT, A. B., SPIJKER, S. & GERAERTS, W. P. (1992). Molluscan
putative prohormone convertases : structural diversity in
the central nervous system of Lymnaea stagnalis. FEBS
Letters 312, 213–218.
STEWART, M. T., MARKS, N. J. & HALTON, D. W. (2003).
Neuroactive substances and associated major muscle
systems in Bucephaloides gracilescens (Trematoda:
Digenea) metacercaria and adult. Parasitology Research
91, 12–21.
STEWART, M. T., MOUSLEY, A., KOUBKOVA, B., SˇEBELOVA´, S.,
MARKS, N. J. & HALTON, D. W. (2003a). Development in
vitro of the neuromusculature of two strigeid
trematodes, Apatemon cobitidis proterorhini and
Cotylurus erraticus. International Journal for
Parasitology 33, 413–424.
STEWART, M. T., MOUSLEY, A., KOUBKOVA, B., SˇEBELOVA´, S.,
MARKS, N. J. & HALTON, D. W. (2003b). Gross anatomy of
the muscle systems and associated innervation of
Apatemon cobitidis proterorhini metacercaria
(Trematoda: Strigeidea), as visualized by confocal
microscopy. Parasitology 126, 273–282.
TENSEN, C. P., COX, K. J., BURKE, J. F., LEURS, R.,
VAN DER SCHORS, R. C., GERAERTS, W. P., VREUGDENHIL, E.
& HEERIKHUIZEN, H. (1998). Molecular cloning and
characterization of an invertebrate homologue of a
neuropeptide Y receptor. European Journal of
Neuroscience 10, 3409–3416.
TERADA, M., ISHII, A. I., KINO, H. & SANO, M. (1982). Studies
on chemotherapy of parasitic helminths (VI) eﬀects of
various neuropharmacological agents on the motility of
Dipylidium caninum. Japanese Journal of Pharmacology
32, 479–488.
WIEST, P. M., LI, Y. N., BURNHAM, D. C., OLDS, G. R. &
BOWEN, W. D. (1992). Schistosoma mansoni :
characterization of phosphoinositide response.
Experimental Parasitology 74, 38–45.
WILLIAMSON, M., HAUSER, F. & GRIMMELIKHUIJZEN, C. J.
(2000). Genomic organization and splicing variants of a
peptidylglycine alpha-hydroxylating monooxygenase
from sea anemones. Biochemical and Biophysical
Research Communications 277, 7–12.
WIPPERSTEG, V., KAPP, K., KUNZ, W., JACKSTADT, W. P.,
ZAHNER, H. & GREVELDING, C. G. (2002). HSP70-
controlled GFP expression in transiently transformed
schistosomes. Molecular and Biochemical Parasitology
120, 141–150.
WIPPERSTEG, V., RIBEIRO, F., LIEDTKE, S., KUSEL, J. R. &
GREVELDING, C. G. (2003). The uptake ofTexas Red-BSA
in the excretory system of schistosomes and its
colocalisation with ER60 promoter-induced GFP in
transiently transformed adult males. International
Journal for Parasitology 33, 1139–1143.
WIPPERSTEG, V., SAJID, M., WALSHE, D., KHIEM, D.,
SALTER, J. P., MCKERROW, J. H., GREVELDING, C. G. &
CAFFREY, C. R. (2005). Biolistic transformation of
Schistosoma mansoni with 5k ﬂanking regions of two
peptidase genes promotes tissue-speciﬁc expression.
International Journal for Parasitology 35, 583–589.
YEW, J. Y., KUTZ, K. K., DIKLER, S., MESSINGER, L., LI, L. &
STRETTON, A. O. (2005). Mass spectrometric map of
neuropeptide expression in Ascaris suum. Journal of
Comparative Neurology 488, 396–413.
ZURAWSKI, T. H., MOUSLEY, A., MAIR, G. R., BRENNAN, G. P.,
MAULE, A. G., GELNAR, M. & HALTON, D. W. (2001).
Immunomicroscopical observations on the nervous
system of adult Eudiplozoon nipponicum (Monogenea:
Diplozoidae). International Journal for Parasitology 31,
783–792.
Neuropeptides in ﬂatworms S55
